Logo image
Caspofungin activity against clinical isolates of fluconazole-resistant Candida
Journal article   Open access   Peer reviewed

Caspofungin activity against clinical isolates of fluconazole-resistant Candida

Michael A Pfaller, Shawn A Messer, Linda Boyken, Cassie Rice, Shailesh Tendolkar, Richard J Hollis and Daniel J Diekema
Journal of clinical microbiology, Vol.41(12), pp.5729-5731
12/2003
DOI: 10.1128/JCM.41.12.5729-5731.2003
PMCID: PMC309007
PMID: 14662968
url
https://doi.org/10.1128/JCM.41.12.5729-5731.2003View
Published (Version of record) Open Access

Abstract

A total of 7,837 clinical isolates of Candida were tested against fluconazole, and 351 resistant (fluconazole MIC >/=64 micro g/ml) isolates were identified (4% of the total tested). All fluconazole-resistant isolates were inhibited by caspofungin at concentrations that can be exceeded by standard doses (MIC at which 90% of the isolates were inhibited, 1 micro g/ml; 99% of the MICs were </=2 micro g/ml).
Antifungal Agents - pharmacology Fluconazole - pharmacology Humans Candida - isolation & purification Peptides - pharmacology Microbial Sensitivity Tests Peptides, Cyclic Candida albicans - drug effects Candida albicans - isolation & purification Candida glabrata - isolation & purification Caspofungin Echinocandins Candida - drug effects Lipopeptides Candida glabrata - drug effects Drug Resistance, Microbial - physiology

Details

Metrics

Logo image